Overview
Lobbying Costs
500,000€ - 599,999€
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
4 Fte (8)
Lobbyists with EP accreditation
3
High-level Commission meetings
83
Lobbying Costs over the years
-
Info
MEDICINES FOR EUROPE (-)
EU Transparency Register
48325781850-28 First registered on 16 Jun 2009
Goals / Remit
Medicines for Europe represents the pharmaceutical companies supplying the largest share of medicines across Europe and is the voice of the generic, biosimilar and value added medicines industries. As a leading partner for better healthcare, we aim to increase the health and wellbeing of all Europeans through better access to high quality medicines. Medicines for Europe members’ portfolio cover 80% of therapy areas, and in so doing, safeguards the sustainability of Europe’s healthcare systems for future generations.
Main EU files targeted
Medicines for Europe plays an important consultative part in European healthcare policy-making and provides key educational role for its members. Medicines for Europe and its members work with European national governments and the EU institutions to develop sustainable solutions for pharmaceutical care and to increase Europe’s competitive strength in the global pharmaceutical medicines market.
Medicines for Europe is engaged to work on a variety of EU pharmaceutical policies and legislative proposals, which include, but is not limited to:
The implementation of the pharmaceutical and IP strategies; The implementation of the SPC Manufacturing Waiver, which was introduced in July 2019; the broad review of the pharmaceutical incentives (e.g. Bolar, variations, orphan and paediatric medicines, etc.); the review of the SPC legislation (i.e. Unitary SPC, SPC legal review, etc.) and the patent system; the industrial policy to stimulate more investments in Active Pharmaceutical Ingredients’ production in Europe and critical medicines ; the possible review of the Transparency Directive on pharmaceutical; the rules on pharmaceuticals’ public procurement; all competition policies aimed to ensure off-patent medicines timely access to the market; all policies related to shortages of medicines; the policy discussions around pharmaceuticals in the environment; education and policies regarding biosimilar medicines; the development of information and awareness around value added medicines; the EMA work around generic and biosimilar medicines; the work of the Pharmaceutical Committee more generally; trade agenda; digital agenda.Address
Head Office
RUE D'ARLON, 50
BRUSSELS 1000
BELGIUMEU Office
RUE D'ARLON, 50
BRUSSELS 1000
BELGIUMWebsite
-
People
Total lobbyists declared
8
Employment time Lobbyists 100% 2 75% 1 25% 5 Lobbyists (Full time equivalent)
4
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
3 accreditations were / are live (in bold) for the selected state of 21 Nov 2024
Name Start date End Date Anna Novosada 03 Oct 2024 31 Jul 2025 Giuliana PENNISI 06 Sep 2024 05 Sep 2025 Luca PROSDOCIMO 08 Jul 2024 07 Jul 2025 Luca PROSDOCIMO 18 May 2023 18 May 2024 Gabriele NICOTRA 19 Jan 2024 04 Oct 2024 Raluca RADU 27 Jul 2023 27 Jul 2024 Giuliana PENNISI 14 Sep 2023 14 Sep 2024 Sophie DAGENS 27 Jul 2023 27 Jul 2024 Mr Adrian van den Hoven 10 Mar 2023 11 Mar 2024 Ms Beata Katarzyna STEPNIEWSKA-KOOLEN 04 Mar 2023 11 Mar 2024 Mr Sergio NAPOLITANO 21 Jan 2023 20 Jan 2024 Gabriele NICOTRA 13 Jan 2023 13 Jan 2024 Giuliana PENNISI 15 Sep 2022 14 Sep 2023 Luca PROSDOCIMO 24 May 2022 18 May 2023 Gabriele NICOTRA 21 Apr 2022 01 Jan 2023 Mr Andrea PUCCI 20 Nov 2021 11 Sep 2022 Maja SERCIC 18 Nov 2021 18 Nov 2022 Riccardo BONANNI 29 Oct 2021 01 Mar 2022 Giuliana PENNISI 13 Sep 2021 14 Sep 2022 Mr Sergio NAPOLITANO 24 Sep 2019 01 Oct 2020 Giuliana PENNISI 13 Jul 2019 11 Jul 2020 Mr Sergio NAPOLITANO 20 Sep 2018 20 Sep 2019 Mr Andrea PUCCI 12 Sep 2018 01 Oct 2019 Giuliana PENNISI 22 Jun 2018 22 Jun 2019 Giuliana PENNISI 18 May 2017 17 May 2018 Julie Chauvet 02 Apr 2016 22 Feb 2017 Julie Chauvet 26 Mar 2015 24 Mar 2016 Julie Chauvet 28 Mar 2014 26 Mar 2015 Julie Chauvet 20 Mar 2013 19 Mar 2014 Julie Chauvet 04 Apr 2012 20 Mar 2013 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade and business associations
-
Networking
Affiliation
• Consultative status with World Intellectual Property Organization (WIPO)
• Founding Member International Generic and Biosimilar Pharmaceutical Alliance (IGBA)
• Member Federation of European and International Associations Established in Belgium (FAIB)Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
500,000€ - 599,999€
Major contributions in closed year
Type Name Amount Grant EU, Horizon Europe 72,821€ Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
500,000€ - 599,999€
Other financial info
The grants indicated above are part of a total grant of 208.062 Euro that is spread over a 5 year period. While in the financial year 1/2023-12/2023 there was no grant (considered 'current financial year' above), on 4 February 2024 Medicines for Europe received a grant of 20 505,91 EUR, still part of the same total grant.
-
EU Structures
Groups (European Commission)
EXPERT GROUP FOR THE IMPLEMENTATION OF THE EU ANTI-TORTURE REGULATION (ATR) #E03762#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3762 #MEMBER #C#Industry#SMEsMedical Device Coordination Group#X03565#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3565 #OBSERVER #C#Industry10 - International Matters#X03565/11#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100607 #OBSERVER #C#IndustryAntimicrobial Resistance One Health Network#E03853#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3853 #MEMBER #C#Industry06 - Borderline and Classification (B&C)#X03565/8#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100603 #OBSERVER #C#Industry
Groups (European Parliament)
N/A
Communication activities
List of activities
• conferences, webinars, communication campaigns and workshops organisation
• membership services and publications (EU Members Brief and highlights)
• scientific, legal and economic assessment reports
• EU and International representationOther activities
None declared
Meetings
Meetings
83 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 18 Apr 2024 Location Brussels Subject Supplementary protection certificates Cabinet Cabinet of Commissioner Thierry Breton Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 05 Oct 2023 Location Brussels Subject Meeting with Medicines for Europe on tackling medicines shortages. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
- Giorgios Rossides (Cabinet member)
-
Date 13 Jul 2023 Location Brussels Subject Meeting with Medicines for Europe on critical medicines Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
- Daphne von Buxhoeveden (Cabinet member)
-
Date 07 Jun 2023 Location Brussels Subject Medicines Security Act Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Peter van Kemseke (Cabinet member)
-
Date 20 Mar 2023 Location Brussels (VTC) Subject Pharma legislation Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Peter van Kemseke (Cabinet member)
-
Date 17 Mar 2023 Location Brussels Subject Revision of the Pharmaceutical legislation Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
-
Date 09 Mar 2023 Location Brussels Subject on the new Pharmaceutical legislation Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Peter van Kemseke (Cabinet member)
-
Date 10 Nov 2022 Location Brussels Subject EU strategic autonomy for the production of active pharmaceutical ingredients Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 10 Nov 2022 Location Brussels Subject will follow Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 09 Nov 2022 Location Online Subject Pharma strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Despina Spanou (Cabinet member)
- Maria Luisa Llano Cardenal (Cabinet member)
-
Date 09 Nov 2022 Location On line Subject Exchange of views on the pharma reform Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
- Giorgios Rossides (Cabinet member)
-
Date 30 Jun 2022 Location Sitges Subject Pharma strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
- Margaritis Schinas (Vice-President)
-
Date 27 Jun 2022 Location videoconference Subject Health industrial ecosystem and supply chains Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 12 May 2022 Location On-line meeting Subject Exchange of views on the upcoming pharmaceutical strategy. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
- Giorgios Rossides (Cabinet member)
-
Date 26 Apr 2022 Location Brussels Subject Meeting with representatives of Medicines for Europe Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
- Stella Kyriakides (Commissioner)
-
Date 26 Apr 2022 Location Brussels Subject Pharma Strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
- Margaritis Schinas (Vice-President)
-
Date 24 Apr 2022 Location berlaymont Subject Supply security & production capacity for critical medicines and ingredients Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 21 Jan 2022 Location Brussels Subject Exchange of views on the role of the generic and bio-similar industry under the EU pharmaceutical strategy. DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 26 Oct 2021 Location Brussels Subject Exchange of views on the upcoming revision of the pharmaceutical legislation and the Health Union Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
-
Date 08 Oct 2021 Location Athens Subject Pharma Strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Krikou (Cabinet member)
- Margaritis Schinas (Vice-President)
-
Date 16 Jun 2021 Location online Subject Supply chains for medicines Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
- Maria Luisa Llano Cardenal (Cabinet member)
Other Lobbyists -
Date 07 Jun 2021 Location Brussels Subject VTC meeting - Access to Medicines Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 05 Mar 2021 Location Brussels Subject VC Meeting discussion on COVID-19 vaccines export authorisation scheme. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 13 Nov 2020 Location Brussels Subject Upcoming Pharmaceutical strategy, links to digital technologies, data and competition. Cabinet Cabinet of Executive Vice-President Margrethe Vestager Portfolio Europe Fit for Digital Age Attending - Kim Jorgensen (Cabinet member)
-
Date 06 Nov 2020 Location Brussels (WEBEX) Subject COVID-19 Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 06 Nov 2020 Location Virtual meeting Subject Covid-19 Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
-
Date 06 Nov 2020 Location Brussels - virtual Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 27 Oct 2020 Location Webex Subject Medicines for Europe - Exchange of views on the upcoming Pharmaceutical Strategy. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
-
Date 27 Oct 2020 Location Virtual Subject Pharma Strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
-
Date 22 Oct 2020 Location Brussels (Webex) Subject Exchange of views on the upcoming pharmaceutical strategy Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Giorgios Rossides (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
Other Lobbyists -
Date 20 Oct 2020 Location Videoconference Subject Production capacity of generic medicines in the EU Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Eszter Batta (Cabinet member)
- Thierry Breton (Commissioner)
Other Lobbyists -
Date 30 Sep 2020 Location Online Subject Call with pharmaceutical and medical device supply Chain on COVID-19 Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
- Giorgios Rossides (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
Other Lobbyists -
Date 17 Jul 2020 Location Brussels Subject Exchange of views on the upcoming Pharmaceutical Strategy Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 29 Jun 2020 Location Online Subject Call with pharmaceutical and medical device industry associations on COVID-19 Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
- Stella Kyriakides (Commissioner)
- Giorgios Rossides (Cabinet member)
Other Lobbyists -
Date 29 Jun 2020 Location Brussels Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 29 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 15 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 08 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 29 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 29 Apr 2020 Location Videconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 23 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 23 Apr 2020 Location Videconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 17 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 09 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 03 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 03 Apr 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 27 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 27 Mar 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 20 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 20 Mar 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 13 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 15 Jul 2019 Location BREY-Brussels Subject Introduce themselves and present the manufacturers of generic medicines general position for the future Commission DG Internal Market, Industry, Entrepreneurship and SMEs Attending - Timo Pesonen (Acting Director-General)
-
Date 05 Jun 2019 Location Brussels Subject Next European Commission holistic strategy for access to off patent medicines; future of pharmaceutical policies; regulatory optimisation; biosimilar medicines; international convergence DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 07 May 2019 Location Brussels, Belgium Subject EU-US issues, EU trade agreements, FTAs DG Trade Attending - Jean-Luc Demarty (Director-General)
-
Date 11 Feb 2019 Location Brussels Subject Supplementary Protection certificate (SPC) Cabinet Cabinet of President Jean-Claude Juncker Portfolio President Attending - Paulina Dejmek Hack (Cabinet member)
-
Date 11 Feb 2019 Location Brussels Subject SPC manufacturing waiver Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Jyrki Katainen (Vice-President)
-
Date 04 Feb 2019 Location Brussels Subject Supplementary Protection Certificates Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 20 Nov 2018 Location Brussels Subject Commission's proposal on a Supplementary Protection Certificate Cabinet Cabinet of President Jean-Claude Juncker Portfolio President Attending - Paulina Dejmek Hack (Cabinet member)
-
Date 25 Oct 2018 Location Brussels Subject Supplementary protection certificate Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 17 Jul 2018 Location Brussels, Belgium Subject Supplementary protection certificate, pharmaceuticals in the environment, AMR Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Annika Nowak (Cabinet member)
-
Date 15 Jun 2018 Location Brussels, Berl Subject HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists -
Date 10 Apr 2018 Location Brussels Subject SPC Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 08 Feb 2018 Location Brussels Subject SPC Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Tomasz Husak (Cabinet member)
- Fabrice Comptour (Cabinet member)
-
Date 30 Jan 2018 Location Brussels Subject Supplementary Protection Certificate Manufacturing Waiver Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Nele Eichhorn (Cabinet member)
-
Date 09 Jan 2018 Location BERL Subject SPC manufacturing waiver Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Fabrice Comptour (Cabinet member)
-
Date 21 Nov 2017 Location Brussels Subject Internal Market's industrial property legal framework relating to supplementary protection certificates (SPC) Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Jyrki Katainen (Vice-President)
-
Date 23 Nov 2016 Location Brussels Subject IPR actions in the single market strategy Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Filomena Chirico (Cabinet member)
-
Date 20 Oct 2016 Location Brussels Subject Follow-up to Council conclusions, AMR Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 05 Jul 2016 Location Brussels Subject Discuss the next Commission Action Plan on antimicrobial resistance (AMR) DG Health and Food Safety Attending - Xavier Prats Monné (Director-General)
-
Date 20 Jun 2016 Location Brussels Subject Biosimilars Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 13 Apr 2016 Location Brussels Subject IP and pharmaceuticals in the EC Single Market Strategy, SPC Manufacturing Waiver proposal Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Marika Lautso-Mousnier (Cabinet member)
-
Date 10 Dec 2015 Location Brussels Subject European healthcare policies DG Health and Food Safety Attending - Xavier Prats Monné (Director-General)
-
Date 16 Oct 2015 Location Brussels Subject Internal Market strategy Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Cécile Billaux (Cabinet member)
-
Date 11 May 2015 Location Brussels Subject Meeting with Beata Stępniewska (EGA Deputy Director General ) Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Elżbieta Bieńkowska (Commissioner)
-
Date 11 May 2015 Location Brussels Subject Introductory meeting Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Rolf Carsten Bermig (Cabinet member)
- Elżbieta Bieńkowska (Commissioner)
-
Date 24 Mar 2015 Location Berlaymont Subject European Union’s policies affecting the pharmaceutical sector Cabinet Cabinet of President Jean-Claude Juncker Portfolio President Attending - Clara Martinez Alberola (Cabinet member)
-
Date 06 Mar 2015 Location Brussels Subject Intro meeting Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Rolf Carsten Bermig (Cabinet member)
- Fabrice Comptour (Cabinet member)
Other Lobbyists -
Date 26 Feb 2015 Location Brussels Subject Generic medicines and biosimilars Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Eveline Lecoq (Cabinet member)
-
Date 18 Feb 2015 Location Brussels Subject Pharmaceutical Industry Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Aura Salla (Cabinet member)
-
Date 04 Feb 2015 Location Brussels Subject EGA manifesto Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Annika Nowak (Cabinet member)
-
Date 20 Jan 2015 Location Brussels (BELGIUM) Subject Exchange of views regarding the EU strategic plan for 2015-2016 and EGA vision DG Health and Food Safety Attending - Ladislav Miko (acting Director-General)
-
Date 18 Dec 2014 Location Brussels Subject Pharma policy coordination; European semester process; COM 2015 workplan for pharmaceuticals. Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Nathalie Chaze (Cabinet member)
-
Date 10 Dec 2014 Location Bruxelles Subject Presentation of the association Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Cécile Billaux (Cabinet member)